BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland

Saved in:
Bibliographic Details
Published inJournal of medical genetics Vol. 40; no. 8; pp. e98 - 98
Main Authors Ikonen, T, Matikainen, M P, Syrjäkoski, K, Mononen, N, Koivisto, P A, Rökman, A, Seppälä, E H, Kallioniemi, O-P, Tammela, T L J, Schleutker, J
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group Ltd 01.08.2003
BMJ Publishing Group LTD
BMJ Group
Subjects
Aged
Aged, 80 and over
allele specific oligonucleotide hybridisation
ASO
BRCA1
BRCA1 and BRCA2
BRCA1 Protein - genetics
BRCA1 Protein - physiology
BRCA2
BRCA2 Protein - genetics
BRCA2 Protein - physiology
Breast cancer
breast cancer predisposing genes
Causality
Finland
Genes
Genes, BRCA1
Genes, BRCA2
Genetic Predisposition to Disease - genetics
Genetic Testing
hereditary prostate cancer
HPC
Humans
Male
Middle Aged
Mutation
Online Mutation Report
Ovarian cancer
PCR
polymerase chain reaction
Prostate cancer
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - genetics
SIR
standardised incidence ratio
Finland
Online AccessGet full text

Cover

More Information
Bibliography:local:0400e98
Correspondence to:
 Dr T Ikonen, Laboratory of Cancer Genetics, Institute of Medical Technology, FIN-33014 University of Tampere, Finland; 
 tarja.ikonen@uta.fi
href:jmedgenet-40-e98.pdf
PMID:12920090
istex:C58C26B2AAA495EAC27DB9D055227415BA830E7B
ark:/67375/NVC-BFWZVN6H-5
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-2593
1468-6244
1468-6244
DOI:10.1136/jmg.40.8.e98